Acebrutololum [INN-Latin]
Brand names,
Acebrutololum [INN-Latin]
Analogs
Acebrutololum [INN-Latin]
Brand Names Mixture
Acebrutololum [INN-Latin]
Chemical_Formula
C18H28N2O4
Acebrutololum [INN-Latin]
RX_link
http://www.rxlist.com/cgi/generic2/ace.htm
Acebrutololum [INN-Latin]
fda sheet
Acebrutololum [INN-Latin]
msds (material safety sheet)
Acebrutololum [INN-Latin]
Synthesis Reference
No information avaliable
Acebrutololum [INN-Latin]
Molecular Weight
336.426 g/mol
Acebrutololum [INN-Latin]
Melting Point
119-123 oC
Acebrutololum [INN-Latin]
H2O Solubility
259 mg/L
Acebrutololum [INN-Latin]
State
Solid
Acebrutololum [INN-Latin]
LogP
2.356
Acebrutololum [INN-Latin]
Dosage Forms
Tablet; Capsule (200 mg and 400 mg)
Acebrutololum [INN-Latin]
Indication
For the management of hypertension and ventricular premature beats in adults.
Acebrutololum [INN-Latin]
Pharmacology
Acebutolol is a cardioselective, beta-adrenoreceptor blocking agent, which possesses mild intrinsic sympathomimetic activity (ISA) in its therapeutically effective dose range. In general, beta-blockers reduce the work the heart has to do and allow it to beat more regularly. Acebutolol has less antagonistic effects on peripheral vascular ß2-receptors at rest and after epinephrine stimulation than nonselective beta-antagonists. Low doses of acebutolol produce less evidence of bronchoconstriction than nonselective agents like propranolol but more than atenolol.
Acebrutololum [INN-Latin]
Absorption
Well absorbed from the Gl tract with an absolute bioavailability of approximately 40% for the parent compound. In
Acebrutololum [INN-Latin]
side effects and Toxicity
Symptoms of overdose include extreme bradycardia, advanced atrioventricular block, intraventricular conduction defects, hypotension, severe congestive heart failure, seizures, and in susceptible patients, bronchospasm, and hypoglycemia.
Acebrutololum [INN-Latin]
Patient Information
Acebrutololum [INN-Latin]
Organisms Affected
Humans and other mammals